FDA.reportPublic FDA data

ALPROSTADIL

Substance profile for UNII F5TD010360, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for ALPROSTADIL
Structure render from PubChem CID 5280723

Substance Identity#

UNII
F5TD010360
Preferred term
ALPROSTADIL
Registry number
745-65-3
EC number
212-017-2
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C20H34O5
Chemical structure for ALPROSTADIL
Structure render from PubChem CID 5280723

Chemical And Database Identifiers#

InChIKey
GMVPRGQOIOIIMI-DWKJAMRDSA-N
SMILES
CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
RxCUI
598
PubChem
5280723
NCIt
C28816
INN ID
4425

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound5280723https://pubchem.ncbi.nlm.nih.gov/compound/5280723
PubChem InChIKey SearchGMVPRGQOIOIIMI-DWKJAMRDSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=GMVPRGQOIOIIMI-DWKJAMRDSA-N
RxNorm598https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=598
NCI ThesaurusC28816https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28816
FDA Substance Registration SystemF5TD010360https://precision.fda.gov/uniisearch/srs/unii/F5TD010360
European Community number212-017-2https://commonchemistry.cas.org/results?q=212-017-2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
AlprostadilACTIVE MOIETYF5TD010360MUSE (ALPROSTADIL) SUPPOSITORY [MEDA PHARMACEUTICALS INC.]10
AlprostadilACTIVE INGREDIENTF5TD010360MUSE (ALPROSTADIL) SUPPOSITORY [MEDA PHARMACEUTICALS INC.]10
ALPROSTADILACTIVE MOIETYF5TD010360PROSTIN VR PEDIATRIC (ALPROSTADIL) INJECTION, SOLUTION [PHARMACIA AND UPJOHN COMPANY]7
ALPROSTADILACTIVE INGREDIENTF5TD010360PROSTIN VR PEDIATRIC (ALPROSTADIL) INJECTION, SOLUTION [PHARMACIA AND UPJOHN COMPANY]7
ALPROSTADILACTIVE INGREDIENTF5TD010360CAVERJECT (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY]6
ALPROSTADILACTIVE MOIETYF5TD010360CAVERJECT (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY]6
ALPROSTADILACTIVE INGREDIENTF5TD010360CAVERJECT IMPULSE (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY]6
ALPROSTADILACTIVE MOIETYF5TD010360CAVERJECT IMPULSE (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY]6
ALPROSTADILACTIVE INGREDIENTF5TD010360EDEX (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ACTIENT PHARMACEUTICALS, LLC]2
ALPROSTADILACTIVE MOIETYF5TD010360EDEX (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ACTIENT PHARMACEUTICALS, LLC]2
AlprostadilACTIVE INGREDIENTF5TD010360ALPROSTADIL INJECTION [TEVA PARENTERAL MEDICINES, INC]1
AlprostadilACTIVE MOIETYF5TD010360ALPROSTADIL INJECTION [TEVA PARENTERAL MEDICINES, INC]1
ALPROSTADILACTIVE MOIETYF5TD010360CAVERJECT IMPULSE (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [U.S. PHARMACEUTICALS]1
ALPROSTADILACTIVE INGREDIENTF5TD010360CAVERJECT IMPULSE (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [U.S. PHARMACEUTICALS]1